| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |